2
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T10160 |
11β-HSD1-IN-1
|
Dehydrogenase | Metabolism |
11β-HSD1-IN-1是1β 羟类固醇脱氢酶Ⅰ型(11β-HSD1,IC50:52nM)的抑制剂,用于治疗疼痛。 | |||
T61593 | 11β-HSD1-IN-6 | ||
11β-HSD1-IN-6 is a potent inhibitor of 11β hydroxysteroid dehydrogenase enzymes (11β-HSDs). These enzymes are responsible for catalyzing the conversion of the active glucocorticoids, corticosterone or cortisol, to their respective inactive forms, 11-dehydrocorticosterone (11-DHC) and cortisone. The compound 11β-HSD1-IN-6 specifically targets and inhibits 11β-HSD-1, effectively modulating the interconversion of these glucocorticoids. [1] |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN4584 |
Morolic acid
|
IL Receptor; COX; HIV Protease | Immunology/Inflammation; Microbiology/Virology; Neuroscience; Proteases/Proteasome |
Morolic acid and moronic acid have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an insulin sensitization with consequent changes of glucose, cholesterol and triglycerides, in part mediated by inhibition of 11β-HSD 1. Moro | |||
TN4585 |
Moronic acid
|
HIV Protease; Antifection; HSV | Microbiology/Virology; Proteases/Proteasome |
Moronic acid shows oral therapeutic efficacy in HSV-infected mice and possessed novel anti-HSV activity. It also shows significant anti-HIV activity (EC(50) 186) and was modified to develop more potent anti-AIDS agents. Moronic acid is a new structural lead for anti-EBV drug development, can substantially reduce the numbers of EBV particles produced by the cells after lytic induction. Morolic and moronic acids have shown sustained antidiabetic and antihyperglycemic action possibly mediated by an... |